Evidence map›Paper›PMID 38862331›Full record

ReviewTrends in neurosciences2024

Emerging modes of regulation of neuromodulatory G protein-coupled receptors.

Alberto J Gonzalez-Hernandez, Hermany Munguba, Joshua Levitz

Abstract readReview
In one paragraph

Review in Trends in neurosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Primary cilia and neural computation.Journal of biomedical science · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. A Chemically Stable Photocaged Noradrenaline.ACS chemical neuroscience · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alberto J Gonzalez-HernandezDepartment of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.
Hermany MungubaDepartment of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA; Department of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
Joshua LevitzDepartment of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA; Department of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: jtl2003@med.cornell.edu.

Funding

Regulation of prefrontal cortical circuit function and reward-seeking behavior by stress-induced dendritic spine remodelingR01MH118451 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI Joshua Levitz, Conor M Liston · 2019 to 2026
$5.5M
Circuit and Synaptic Mechanisms of Endocannabinoid-Opioid CrosstalkR01DA054368 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Francis Sang Yong Lee, Anjali M Rajadhyaksha · 2022 to 2026
$3.5M
Photopharmacological interrogation of presynaptic neuromodulation of cortico-amygdalar circuitsR01MH129693 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI Joshua Levitz · 2022 to 2026
$3.1M
Molecular and Synaptic Mechanisms of Neurotrophin-glutamate CrosstalkR01NS126590 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Francis Sang Yong Lee, Joshua Levitz · 2022 to 2026
$2.8M
Mechanisms of Regulation of Metabotropic Glutamate ReceptorsR01NS129904 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Joshua Levitz · 2023 to 2026
$2.6M
Mechanisms of Regulation of Neuronal GPCRs by KCTDsR01NS131463 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Andrew Kruse, Joshua Levitz · 2024 to 2026
$2.0M
Genetically-Targeted Photo-Pharmacology for Native Opioid ReceptorsR33DA051529 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVITZ, JOSHUA, TRAUNER, DIRK HARTWIG · 2023 to 2024
$1.2M
NIDA NIH HHS R01 DA054368NIDA NIH HHS R33 DA051529NIMH NIH HHS R01 MH118451NIMH NIH HHS R01 MH129693NINDS NIH HHS R01 NS126590NINDS NIH HHS R01 NS129904NINDS NIH HHS R01 NS131463
6 · The paper itself

Abstract

In the nervous system, G protein-coupled receptors (GPCRs) control neuronal excitability, synaptic transmission, synaptic plasticity, and, ultimately, behavior through spatiotemporally precise initiation of a variety of signaling pathways. However, despite their critical importance, there is incomplete understanding of how these receptors are regulated to tune their signaling to specific neurophysiological contexts. A deeper mechanistic picture of neuromodulatory GPCR function is needed to fully decipher their biological roles and effectively harness them for the treatment of neurological and psychiatric disorders. In this review, we highlight recent progress in identifying novel modes of regulation of neuromodulatory GPCRs, including G protein- and receptor-targeting mechanisms, receptor-receptor crosstalk, and unique features that emerge in the context of chemical synapses. These emerging principles of neuromodulatory GPCR tuning raise critical questions to be tackled at the molecular, cellular, synaptic, and neural circuit levels in the future.

Indexed as

Receptors, G-Protein-CoupledSignal TransductionAnimalsHumansNeuronal PlasticityNeuronsNeurotransmitter AgentsSynapsesSynaptic TransmissionNeurotransmitter AgentsReceptors, G-Protein-CoupledcrosstalkGABAB receptormetabotropic glutamate receptoropioid receptorsynapsetrafficking

Identifiers

PMID38862331
PMCPMC11324403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.